An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...

Earlier this week, researchers presented data from the OPTIMUM (Optimization of Prostate Biopsy – Micro-Ultrasound Versus MRI) trial at the European Association of Urology Congress in Madrid, Spain.

A new randomized clinical trial found that men with localized, intermediate‑risk prostate cancer recovered faster and ...

It’s the second most common type of cancer among men and affects 1 in every 8 men in the United States. September is Prostate Cancer Awareness Month, and the American Cancer Society says this type of ...

Researchers from Rice University and Vanderbilt University have made significant advancements in the fight against prostate cancer. They have shown that combining a small-molecule therapy called tumor ...

The Society of Interventional Radiology (SIR) announced that the CAPTAIN randomized clinical trial found that men with ...

A recent randomized clinical trial has found that men with localized, intermediate-risk prostate cancer recovered faster and ...

An ultrasound-based treatment for prostate cancer showed better safety and operative metrics versus robotic radical prostatectomy in an early analysis of a first-ever randomized trial. After 6 months ...

Routine prostate cancer screenings save lives, yet some men still avoid them. However, making the process more streamlined increases the likelihood that men will get the tests they need to catch ...

The 2 groups--those receiving ultra-hypofractionated radiotherapy and conventionally fractionated radiotherapy--had similar overall survival, which was 81% and 79%, respectively, at 10 years.

UHF noninferior to conventionally fractionated radiotherapy for men with intermediate- to high-risk localized disease. (HealthDay News) — Ultra-hypofractionated (UHF) radiotherapy delivered over two ...